Rebound pustular psoriasis after brodalumab discontinuation
- 9 August 2016
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 175 (5) , 1065-1066
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisNew England Journal of Medicine, 2015
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trialsThe Lancet, 2015
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 TrialsNew England Journal of Medicine, 2014
- Serum and tissue levels of IL-17 in different clinical subtypes of psoriasisArchives of Dermatological Research, 2012
- A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesisBritish Journal of Dermatology, 2010